Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Surgical Sciences, University of Pavia, Pavia, Italy.
Gastrointestinal Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, University of Milan, Milan, Italy.
J Am Coll Surg. 2018 Jun;226(6):1147-1159. doi: 10.1016/j.jamcollsurg.2018.03.025. Epub 2018 Mar 21.
Transplantable hepatocellular carcinoma (HCC) represents a highly debated issue due to the overlap between indications for liver resection (LR) and transplantation (LT) in patients suitable for both.
Between January 2000 and December 2012, five hundred and twenty-four transplantable patients affected by HCC were identified among resected patients. Two regression models were constructed to classify patients into 2 groups pre-low and pre-high risk based on preoperative variables and then to reclassify pre-low-risk patients according to postoperative variables into either post-low or post-high-risk. Additionally, a cohort of patients with comparable baseline characteristics who underwent LT were similarly classified into pre-low and pre-high-risk groups and compared with the resected patients in terms of survival.
Cirrhosis, aspartate transaminase, α-fetoprotein, Model for End-Stage Liver Disease score, number of nodules, and diameter of the largest nodule were preoperatively found to be significantly related to overall survival post-LR. Microvascular invasion and satellites were selected to reclassify prognosis in the resulting preoperative low-risk group into post-high risk. The converted group (post-high) demonstrated the same 5-year survival as the pre-high group. Patients undergoing LT had better survival overall than those undergoing LR, with the exception of pre-low LT and post-low LR (confirmed low-risk LR) who had similar outcomes.
The new models were strongly predictive of patients' likelihood of survival after LR for HCC on liver cirrhosis. Liver transplantation offers a survival advantage over LR, except in low-risk groups where both modalities might be comparable.
可移植性肝细胞癌(HCC)是一个备受争议的问题,因为在适合两者的患者中,肝切除术(LR)和肝移植(LT)的适应证存在重叠。
2000 年 1 月至 2012 年 12 月,在接受切除术的患者中确定了 524 例患有 HCC 的可移植患者。根据术前变量构建了两个回归模型,将患者分为 2 组:低危和高危,然后根据术后变量将低危患者重新分类为低危或高危。此外,对接受 LT 的具有可比基线特征的患者进行类似分类,将其分为低危和高危组,并根据生存情况与接受切除术的患者进行比较。
肝硬化、天门冬氨酸转氨酶、甲胎蛋白、终末期肝病模型评分、结节数量和最大结节直径术前发现与 LR 后总生存率显著相关。微血管侵犯和卫星灶被选择用于重新分类术前低危组的预后为高危。转换组(高危)与预高危组的 5 年生存率相同。LT 患者的总体生存率优于 LR 患者,除了 LT 低危和 LR 低危(确认的低危 LR)患者的生存率相似。
新模型强烈预测了 HCC 肝硬化患者接受 LR 后生存的可能性。肝移植提供了优于 LR 的生存优势,除了低危组,两者可能相当。